Clinical Trial Update: Renal Mechanism of SGLT2 Inhibition [Phase 2]

View source ↗

Summary

Phase 2 clinical trial sponsored by the University of Colorado, Denver is investigating the renal mechanism of SGLT2 inhibition in people with Type 2 diabetes m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Kidney Disease
• Type 2 Diabetes Mellitus

Snippet

Sponsor: University of Colorado, Denver | Conditions: Type 2 Diabetes, Diabetic Kidney Disease | Phase 2 | Status: RECRUITING